Last updated June 2026
Investing in early-stage startups is high-risk. Read this before you invest. PoolVen vets every listing, but vetting reduces risk — it does not remove it.
Most startups fail. You should only invest money you can afford to lose entirely, and diversify rather than concentrate in a single raise.
Startup equity is hard to sell. The PoolVen secondary market may let you list a stake, but there is no guarantee of a buyer or a particular price, and transfers complete only after approval.
Early-stage companies rarely pay dividends and reinvest profits. Returns, if any, typically come only on an exit that may never happen.
Funds release to founders only as vetted milestones are met, which protects against some misuse — but it cannot guarantee the business succeeds.
Nothing on PoolVen is personalised investment advice. If unsure, consult an independent, CMA-licensed financial adviser before investing.
